Attached files
| file | filename |
|---|---|
| EX-10.11 - EMPLOYMENT AGREEMENT DATED SEPTEMBER 24, 2020 BY AND BETWEEN THE REGISTRANT AND - TFF Pharmaceuticals, Inc. | f10k2020ex10-11_tffpharma.htm |
| EX-32.1 - CERTIFICATION - TFF Pharmaceuticals, Inc. | f10k2020ex32-1_tffpharma.htm |
| EX-31.2 - CERTIFICATION - TFF Pharmaceuticals, Inc. | f10k2020ex31-2_tffpharma.htm |
| EX-31.1 - CERTIFICATION - TFF Pharmaceuticals, Inc. | f10k2020ex31-1_tffpharma.htm |
| EX-4.4 - DESCRIPTION OF CAPITAL STOCK - TFF Pharmaceuticals, Inc. | f10k2020ex4-4_tffpharma.htm |
| 10-K - ANNUAL REPORT - TFF Pharmaceuticals, Inc. | f10k2020_tffpharma.htm |
Exhibit 23.1
Independent Registered Public Accounting Firm’s Consent
We consent to the incorporation by reference in the Registration Statement of TFF Pharmaceuticals, Inc. on Form S-3 (File No. 333-249870) and Form S-8 (File No. 333-249364) of our report dated March 10, 2021, with respect to our audits of the consolidated financial statements of TFF Pharmaceuticals, Inc. as of December 31, 2020 and 2019 and for each of the two years in the period ended December 31, 2020, which report is included in this Annual Report on Form 10-K of TFF Pharmaceuticals, Inc. for the year ended December 31, 2020.
/s/ Marcum llp
Marcum llp
New York, NY
March 10, 2021